India approves Eli Lilly’s Mounjaro KwikPen, a once-weekly injection for type 2 diabetes and obesity, offering dual hormone ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...

Signs of advanced chronic pancreatitis include weight loss, a loss of appetite, jaundice, other symptoms associated with ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...

However, if you're planning to ask your GP to prescribe it, are you actually eligible and do you meet the very specific ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

For the first time, 40-year-old Manmeet Bindra feels motivated to exercise and has set up a home gym, cleaned up her diet and ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...